Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KRX/326030 stock hub

KRX/326030 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/326030is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.8T

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/326030

In the news

Latest news · KRX/326030

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E26.6

P25 9.8P50 17.1P75 31.9

Trailing P/E29.2

P25 12P50 23.1P75 39.5

ROE36.2

P25 -17.1P50 0.7P75 8.5

ROIC38.9

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/326030 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

205

Groups with data

Currency

KRW

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	246
Enterprise value	KRW 7.5T
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biotechnology
Isin	KR7326030004
Last refreshed	2026-05-10
Market cap	KRW 7.8T
Price	KRW 99,400
Price currency	KRW
Rev Per Employee	2,872,930,732.93x
Sector	Healthcare
Sic	2834
Symbol	krx/326030
Website	https://www.skbp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.43%
EV Earnings	28.23x
EV/EBIT	44.43x
EV/EBITDA	40.4x
EV/FCF	44.48x
EV/Sales	10.66x
FCF yield	2.18%
Forward P/E	26.57x
P/B ratio	9.42x
P/E ratio	29.16x
P/S ratio	11.01x
PEG ratio	2.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	28.86%
EBITDA Margin	31.25%
FCF margin	23.98%
Gross margin	93.93%
Gross Profit	KRW 663.8B
Gross Profit Growth	31.58%
Gross Profit Growth Q	14.17%
Gross Profit Growth3 Y	47.13%
Gross Profit Growth5 Y	94.21%
Net Income	KRW 267B
Net Income Growth	10.89%
Net Income Growth Q	-28.15%
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Pretax Margin	21.35%
Profit Margin	37.77%
Profit Per Employee	KRW 1.1B
Profitable Years	2
ROA	11.41
Roa5y	2.54
ROCE	22.58
ROE	36.17
Roe5y	10.98
ROIC	38.91
Roic5y	17.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.4%
Cagr3y	10.89%
Cagr5y	-1.65%
EPS Growth	10.89
EPS Growth Q	-28.17
EPS Growth Quarters	1
EPS Growth Years	3
FCF Growth	81.21%
FCF Growth Q	46.9%
OCF Growth	85.81%
OCF Growth Q	53.04%
Revenue Growth	29.06x
Revenue Growth Q	19.22x
Revenue Growth Quarters	13x
Revenue Growth Years	3x
Revenue Growth3 Y	42.12x
Revenue Growth5 Y	93.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.63
Assets	KRW 1.2T
Cash	KRW 309.5B
Current Assets	KRW 683.2B
Current Liabilities	KRW 295.2B
Debt	KRW 48.9B
Debt EBITDA	KRW 0.22
Debt Equity	KRW 0.06
Debt FCF	KRW 0.29
Equity	KRW 826.3B
Interest Coverage	26.52
Liabilities	KRW 372B
Long Term Assets	KRW 515.1B
Long Term Liabilities	KRW 76.8B
Net Cash	KRW 260.6B
Net Cash By Market Cap	KRW 3.35
Net Cash Growth	86.11%
Net Debt EBITDA	KRW -1.18
Net Debt Equity	KRW -0.32
Net Debt FCF	KRW -1.54
Tangible Book Value	KRW 806B
Tangible Book Value Per Share	KRW 10,293
WACC	8.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.31
Inventory Turnover	0.4
Net Working Capital	KRW 87B
Quick ratio	1.83
Working Capital	KRW 388B
Working Capital Turnover	KRW 2.2

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.4%
200-day SMA	110,648.5
3Y total return	36.35%
50-day SMA	100,654
50-day SMA vs 200-day SMA	50under200
5Y total return	-7.96%
All Time High	269,500
All Time High Change	-63.12%
All Time High Date	2020-07-07
All Time Low	50,900
All Time Low Change	95.28%
All Time Low Date	2022-10-13
ATR	3,245.7
Beta	0.79
Beta1y	1.18
Beta2y	0.7
Ch YTD	-20.22
High	102,000
High52	144,100
High52 Date	2025-11-28
High52ch	-31.02%
Low	98,500
Low52	86,900
Low52 Date	2025-05-12
Low52ch	14.38%
Ma50ch	-1.25%
Price vs 200-day SMA	-10.17%
RSI	46.06
RSI Monthly	47.64
RSI Weekly	42.83
Sharpe ratio	0x
Sortino ratio	0.14
Tr YTD	-20.22
Tr1m	4.52%
Tr1w	0.1%
Tr3m	-8.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 203.9B
Operating Income Growth	111.7
Operating Income Growth Q	13.83
Operating margin	28.86

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38,967,222%
Net Borrowing	-156,677,758,560
Shares Insiders	0.05%
Shares Institutions	12.58%
Shares Out	78,313,250
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 165.8B
Average Volume	177,013.3x
Bv Per Share	10,381.8
CAPEX	KRW -6.9B
Ch1m	4.52
Ch1w	0.1
Ch1y	0.4
Ch3m	-8.39
Ch3y	36.35
Ch5y	-7.96
Ch6m	-14.31
Change	-0.2%
Change From Open	-2.36
Close	99,600
Days Gap	2.21
Depreciation Amortization	16,947,248,000
Dollar Volume	17,268,066,200
Earnings Date	2026-05-07
EBIT	KRW 203.9B
EBITDA	KRW 220.9B
EPS	KRW 3,409
F Score	6
FCF	KRW 169.4B
FCF EV Yield	2.25x
FCF Per Share	KRW 2,164
Financing CF	-156,677,758,560
Fiscal Year End	December
Founded	1,993
Goodwill	1,650,296,000
Graham Number	28217.99771
Graham Upside	-71.61
Income Tax	KRW -102.4B
Investing CF	-35,420,110,190
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2025-12-31
Ma150	113,333.3
Ma150ch	-12.29%
Ma20	101,495
Ma20ch	-2.06%
Net CF	-15,036,392,090
Next Earnings Date	2026-05-11
Open	101,800
P FCF Ratio	45.94
P OCF Ratio	44.15
Position In Range	25.71
Ppne	60,510,217,350
Price Date	2026-05-08
Price EBITDA	KRW 35.24
Ptbv Ratio	9.66
Relative Volume	0.98x
Revenue	706,740,960,300x
SBC By Revenue	0.51x
Share Based Comp	3,633,430,000
Tax By Revenue	-14.48x
Tr6m	-14.31%
Volume	173,723
Z Score	14.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRX/326030 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/326030 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/326030?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.6%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/326030 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.1

Neutral momentum band

Price vs 200-day MA

-10.2%

50/200-day relationship not available

Beta (5Y)

0.79

Less volatile than the market

Sharpe ratio

0.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/326030

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/326030 stock rating?

krx/326030 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/326030 analysis?

The full report lives at /stocks/krx/326030/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/326030?

The latest report frames krx/326030 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/326030 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.